Squarepoint Ops LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$172,091
-20.8%
132,378
-1.3%
0.00%
-100.0%
Q2 2023$217,310
+382.9%
134,142
+168.9%
0.00%
Q1 2022$45,000
-70.2%
49,878
+176.3%
0.00%
Q3 2021$151,000
-69.6%
18,049
-76.0%
0.00%
-100.0%
Q1 2021$497,000
+498.8%
75,196
+279.7%
0.00%
+200.0%
Q4 2020$83,000
-50.9%
19,805
+85.1%
0.00%
-50.0%
Q4 2018$169,00010,7000.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders